163 related articles for article (PubMed ID: 36832045)
1. A Multiple-Array SPRi Biosensor as a Tool for Detection of Gynecological-Oncological Diseases.
Szymanska B; Lukaszewski Z; Hermanowicz-Szamatowicz K; Gorodkiewicz E
Biosensors (Basel); 2023 Feb; 13(2):. PubMed ID: 36832045
[TBL] [Abstract][Full Text] [Related]
2. An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma.
Szymanska B; Lukaszewski Z; Zelazowska-Rutkowska B; Hermanowicz-Szamatowicz K; Gorodkiewicz E
Sensors (Basel); 2021 May; 21(10):. PubMed ID: 34065481
[TBL] [Abstract][Full Text] [Related]
3. Two Biosensors for the Determination of Interleukin-6 in Blood Plasma by Array SPRi.
Szymanska B; Lukaszewski Z; Oldak L; Zelazowska-Rutkowska B; Hermanowicz-Szamatowicz K; Gorodkiewicz E
Biosensors (Basel); 2022 Jun; 12(6):. PubMed ID: 35735559
[TBL] [Abstract][Full Text] [Related]
4. A biosensor for determination of the circulating biomarker CA125/MUC16 by Surface Plasmon Resonance Imaging.
Szymańska B; Lukaszewski Z; Hermanowicz-Szamatowicz K; Gorodkiewicz E
Talanta; 2020 Jan; 206():120187. PubMed ID: 31514860
[TBL] [Abstract][Full Text] [Related]
5. An Immunosensor for the Determination of Cathepsin S in Blood Plasma by Array SPRi-A Comparison of Analytical Properties of Silver-Gold and Pure Gold Chips.
Falkowski P; Mrozek P; Lukaszewski Z; Oldak L; Gorodkiewicz E
Biosensors (Basel); 2021 Aug; 11(9):. PubMed ID: 34562888
[TBL] [Abstract][Full Text] [Related]
6. Detection of serum human epididymis secretory protein 4 in patients with ovarian cancer using a label-free biosensor based on localized surface plasmon resonance.
Yuan J; Duan R; Yang H; Luo X; Xi M
Int J Nanomedicine; 2012; 7():2921-8. PubMed ID: 22745553
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Various Chips Used for the Manufacture of Biosensors Applied in Non-Fluidic Array SPRi, Based on the Example of Determination of Cathepsin D.
Falkowski P; Mrozek P; Miluski P; Lukaszewski Z; Gorodkiewicz E
Biosensors (Basel); 2021 Dec; 12(1):. PubMed ID: 35049649
[TBL] [Abstract][Full Text] [Related]
8. An Array SPRi Biosensor for the Determination on PARP-1 in Blood Plasma.
Zielinska Z; Oldak L; Kacperczyk-Bartnik J; Koc-Żórawska E; Żórawski M; Laudanski P; Gorodkiewicz E
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831138
[TBL] [Abstract][Full Text] [Related]
9. Two Biosensors for the Determination of VEGF-R2 in Plasma by Array SPRi.
Oldak L; Zelazowska-Rutkowska B; Lesniewska A; Mrozek P; Skoczylas M; Lukaszewski Z; Gorodkiewicz E
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615347
[TBL] [Abstract][Full Text] [Related]
10. Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response.
Hamed EO; Ahmed H; Sedeek OB; Mohammed AM; Abd-Alla AA; Abdel Ghaffar HM
Diagn Pathol; 2013 Jan; 8():11. PubMed ID: 23343214
[TBL] [Abstract][Full Text] [Related]
11. Multiple Biomarker Simultaneous Detection in Serum via a Nanomaterial-Functionalized Biosensor for Ovarian Tumor/Cancer Diagnosis.
Wu Y; Wang C; Wang C; Wang P; Chang X; Han L; Zhang Y
Micromachines (Basel); 2022 Nov; 13(12):. PubMed ID: 36557345
[TBL] [Abstract][Full Text] [Related]
12. Consideration should be given to smoking, endometriosis, renal function (eGFR) and age when interpreting CA125 and HE4 in ovarian tumor diagnostics.
Lycke M; Ulfenborg B; Malchau Lauesgaard J; Kristjansdottir B; Sundfeldt K
Clin Chem Lab Med; 2021 Nov; 59(12):1954-1962. PubMed ID: 34388324
[TBL] [Abstract][Full Text] [Related]
13. An Array SPRi Biosensor for the Determination of Follicle-Stimulating Hormone in Blood Plasma.
Sankiewicz A; Zelazowska-Rutkowska B; Lukaszewski Z; Hermanowicz A; Gorodkiewicz E
Sensors (Basel); 2023 Dec; 23(24):. PubMed ID: 38139531
[TBL] [Abstract][Full Text] [Related]
14. HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients.
Braicu EI; Krause CL; Torsten U; Mecke H; Richter R; Hellmeyer L; Lanowska M; Müller B; Koch E; Boenneß-Zaloum J; Ames K; Chekerov R; Hasenbein K; Zimmermann M; Mangler M; Chen F; Tauber R; Sehouli J
BMC Cancer; 2022 Jul; 22(1):831. PubMed ID: 35907794
[TBL] [Abstract][Full Text] [Related]
15. Two SPRi biosensors for the determination of cathepsin S in blood plasma.
Oldak L; Sankiewicz A; Żelazowska-Rutkowska B; Cylwik B; Lukaszewski Z; Skoczylas M; Gorodkiewicz E
Talanta; 2021 Apr; 225():121900. PubMed ID: 33592693
[TBL] [Abstract][Full Text] [Related]
16. HE4 combined with CA125: favorable screening tool for ovarian cancer.
Ghasemi N; Ghobadzadeh S; Zahraei M; Mohammadpour H; Bahrami S; Ganje MB; Rajabi S
Med Oncol; 2014 Jan; 31(1):808. PubMed ID: 24323399
[TBL] [Abstract][Full Text] [Related]
17. Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer.
Park Y; Kim Y; Lee EY; Lee JH; Kim HS
Int J Cancer; 2012 Mar; 130(5):1136-44. PubMed ID: 21484794
[TBL] [Abstract][Full Text] [Related]
18. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract][Full Text] [Related]
19. Serum HE4 is more suitable as a biomarker than CA125 in Chinese women with benign gynecologic disorders.
Zhang Y; Qiao C; Li L; Zhao X; Li Y
Afr Health Sci; 2014 Dec; 14(4):913-8. PubMed ID: 25834501
[TBL] [Abstract][Full Text] [Related]
20. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers].
Nyangoh-Timoh K; Bendifallah S; Dion L; Ouldamer L; Levêque J
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):277-286. PubMed ID: 32004789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
